We are specializing in innovative drugs for external use pertaining to immune inflammatory targets. Currently, PrimeGene’s product lines cover atopic dermatitis, prurigo nodularis, epidermolysis bullosa, allergic rhinitis, glaucoma, and our products all are developed independently. PrimeGene owns global rights and interests.